narsoplimab
Drug Details
- Generic Name
- narsoplimab
- Brand Names
- YARTEMLEA
- Application Number
- BLA761152
- Sponsor
- Omeros Corporation
- NDC Codes
- 2
- Dosage Forms
- INJECTION, LIQUID
- Routes
- INTRAVENOUS
- Active Ingredients
- NARSOPLIMAB
Indications and Usage
1 INDICATIONS AND USAGE YARTEMLEA is indicated for the treatment of adult and pediatric patients 2 years of age and older with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). YARTEMLEA is a MASP-2 inhibitor indicated for the treatment of adult and pediatric patients 2 years of age and older with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). ( 1 )